L-arginine during long-term ischemia: Effects on cardiac function, energetic metabolism and endothelial damage

Journal of Heart and Lung Transplantation

Volumn 19, Issue 4, 2000, Pages 367-376

  Desrois, Martine ^a   Sciaky, Martine ^a   Lan, Carole ^a   Cozzone, Patrick J ^a   Bernard, Monique ^a  

^a University of Aix Marseille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARDIOPLEGIC AGENT; PAPAVERINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENERGY METABOLISM; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PRESERVATION; HEMODYNAMICS; ISOLATED HEART; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; ARGININE; CARDIOPLEGIC SOLUTIONS; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; ENERGY METABOLISM; HEMODYNAMIC PROCESSES; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL ISCHEMIA; ORGAN PRESERVATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0034086336     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00063-2     Document Type: Article

References (58)

1. Van Benthuysen K.M., Mc Murtry I.F., Horowitz L.D. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 79:1987;265-274.
2. Tsao P.S., Aoki N., Lefer D.J., Johnson G., Lefer A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 82:1990;1402-1412.
3. Weyrich A.S., Xin-liang M.A., Lefer A.M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 86:1992;279-288.
4. Pernow J., Uriuda Y., Wang Q.D., Li X.S., Nordlander R., Rydeen L. The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J. 15:1994;1712-1719.
5. Sato H., Zhao Z.Q., McGee S.D., Williams M.W., Hammon J.W., Vinten-Johansen J. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg. 110:1995;302-314.
6. Pinsky D.J., Oz M.C., Koga S., et al. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest. 93:1994;2291-2297.
7. Ma X.L., Weyrich A.S., Lefer D.J., Lefer A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 72:1993;403-412.
8. Amrani M., Chester A.H., Jayakumar J., Schyns C.J., Yacoub M.H. L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res. 30:1995;200-204.
9. Nakanishi K., Vinten-Johansen J., Lefer D.J., et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol. 263:1992;H1650-H1658.
10. Mizuno T., Watanabe M., Sakamoto T., Sunamori M. L-arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1, 4, 5-triphosphate. J Thorac Cardiovasc Surg. 115:1998;931-936.
11. Hiramatsu T., Forbess J.M., Miura T., Mayer J.E. Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. J Thorac Cardiovasc Surg. 109:1995;81-87.
12. Hiramatsu T., Forbess J.M., Miura T., Mayer J.E. Effect of L-arginine cardioplegia on recovery of neonatal lamb hearts after 2 hours of cold ischemia. Ann Thorac Surg. 60:1995;1187-1192.
13. Hiramatsu T., Forbess J.M., Miura T., Roth S.J., Cioffi M.A., Mayer J.E. Effects of endothelin-1 and L-arginine after cold ischemia in lamb hearts. Ann Thorac Surg. 61:1996;36-41.
14. Amrani M, Gray CC, Smolenski RT, Goodwin AT, London A, Yacoub MH. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia. Circulation 1997;96(suppl II):II274-9.
15. Li X.-S., Uriuda Y., Wang Q.-D., Nordlander R., Sjoquist P.-O., Pernow J. Role of L-arginine in preventing myocardial and endothelial injury following ischemia/reperfusion in the rat isolated heart. Acta Physiol Scand. 156:1996;37-44.
16. 2+-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol. 29:1997;291-296.
17. Hiramatsu T., Forbess J.M., Miura T., Nomura F., Mayer J.E. Additive effects of L-arginine infusion and leucocyte depletion on recovery after hypothermic ischemia in neonatal lamb hearts. J Thorac Cardiovasc Surg. 110:1995;172-179.
18. Mizuno A., Baretti R., Buckberg G.D., et al. Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle a role of L-arginine blood cardioplegia. J Thorac Cardiovasc Surg. 113:1997;379-389.
19. Carrier M., Khalil A., Tourigny A., Solymoss B.C., Pelletier L.C. Effect of L-arginine on metabolic recovery of the ischemic myocardium. Ann Thorac Surg. 61:1996;1651-1657.
20. Izhar U., Schwalb H., Borman J.B., Merin G. Cardioprotective effect of L-arginine in myocardial ischemia and reperfusion in an isolated working rat heart model. J Cardiovasc Surg. 39:1998;321-329.
21. Kevelaitis E., Mouas C., Menasché P. Poststorage diastolic abnormalities of heart transplants is vascular dysfunction or myocardial contracture the culprit? J Heart Lung Transplant. 15:1996;461-469.
22. Schulz R., Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia-reperfusion injury. Cardiovasc Res. 30:1995;432-439.
23. G-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol. 27:1995;419-426.
24. Takeuchi K., McGowan F.X., Danh H.C., Glynn P., Simplaceanu E., Del Nido P.J. Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to myocardium. J Mol Cell Cardiol. 27:1995;1405-1414.
25. Matheis G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.H., Ignarro L.J. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol. 262:1992;H616-H620.
26. Bernard M., Caus T., Sciaky M., Lan C., Cozzone P.J. Optimized cardiac graft preservation a comparative experimental study using P-31 magnetic resonance spectroscopy and biochemical analyses. J Heart Lung Transplant. 18:1999;572-581.
27. Cannon M.B., Vine A.J., Kantor H.L., et al. Warm and cold blood cardioplegia, comparison of myocardial function and metabolism using 31-P magnetic resonance spectroscopy. Circulation. 90:1994;II328-II38.
28. 31P nuclear magnetic resonance analysis of metabolite concentrations in Langendorff-perfused rabbit hearts. Biophys J. 48:1985;803-813.
29. Karck M., Vivi A., Tassini M., et al. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery. J Thorac Cardiovasc Surg. 104:1992;1356-1364.
30. Kost G.J. pH standardization for phosphorus-31 magnetic resonance heart spectroscopy at different temperatures. Magn Reson Med. 14:1990;496-506.
31. Rosalki S.B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 69:1967;696-705.
32. Ames B.N. Assay of inorganic phosphates, total phosphate and phosphatases. Methods Enzymol. 8:1966;115-118.
33. Gutman I. Determination with lactate dehydrogenase and NAD. In: HU B. Methods of enzymatic analysis. New York: Academic Press, 1974, pp. 266-70.
34. Wynants J., Petrov B., Nijhof J., Van Belle H. Optimization of a HPLC method for the determination of nucleosides and their catabolites. Application to cat and rabbit heart perfusates. J Chromatogr. 386:1987;297-308.
35. Lowry O.H., Rosebrough N.J., Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
36. Bernstein L.K., Everse J. Determination of the isoenzyme levels of lactate dehydrogenase. Methods Enzymol. 41:1975;47-52.
37. Saldanha C., Hearse D.J. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. J Thorac Cardiovasc Surg. 98:1989;783-787.
38. Mankad P.S., Chester A.H., Yacoub M.H. Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg. 51:1991;89-93.
39. Mankad P.S., Amrani M., Rothery S., Severs N.J., Yacoub M.H. Relative susceptibility of endothelium and myocardial cells to ischaemia-reperfusion injury. Acta Physiol Scand. 161:1997;103-112.
40. Portmann M., Eyster G. Myocardial buffering capacity and high-energy phosphates utilization during hypothermic circulatory arrest and recovery in the newborn lamb in vivo. J Thorac Cardiovasc Surg. 108:1994;946-952.
41. Ali I.S., Gandhi M., Finegan B.A., Koshal A., Clanachan A.S. Cardioprotection by activation of NO/cGMP pathway after cardioplegic arrest and 8-hour storage. Ann Thorac Surg. 65:1998;1303-1309.
42. Engelman D.T., Watanabe M., Engelman R.M., et al. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg. 110:1995;1047-1053.
43. Smulders R.A., Aarsen M., Teerlink T., et al. Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects L-arginine-induced vasodilatation cannot be explained by non-specific effects of cationic amino acids. Clin Sci. 92:1997;367-374.
44. Mankad P.S., Chester A.H., Yacoub M.H. 5-hydroxytryptamine mediates endothelial dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide. Cardiovasc Res. 25:1991;244-248.
45. Seccombe J.F., Pearson P.J., Schaff H.V. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J Thorac Cardiovasc Surg. 107:1994;505-509.
46. Mollace V., Salvemini D., Anggard E., Vane J. Nitric oxide from vascular smooth muscle cells regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br J Pharmacol. 104:1991;633-638.
47. Grocott-Mason R., Fort S., Lewis M.J., Shah A.M. Myocardial relaxant effect of exogenous nitric oxide in the isolated ejecting heart. Am J Physiol. 266:1994;H1699-H1705.
48. Kitakaze M., Node K., Komamura K., et al. Evidence for nitric oxide generation in the cardiomyocytes; its augmentation by hypoxia. J Mol Cell Cardiol. 27:1995;2149-2154.
49. Paulus W.J., Vantrimpont P.J., Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation. 89:1994;2070-2078.
50. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 87:1990;1620-1624.
51. Jeffrey F.M.H., Storey C.J., Malloy C.R. Predicting functional recovery from ischemia in the rat myocardium. Basic Res Cardiol. 87:1992;548-558.
52. Jeremy R.W., Ambrosio G., Pike M.M., Jacobus W.E., Becker L.C. The functional recovery of post-ischemic myocardium requires glycolysis during early reperfusion. J Mol Cell Cardiol. 25:1993;261-276.
53. Lohmann S.M., Fischmeister R., Walter U. Signal transduction by cGMP in heart. Basic Res Cardiol. 86:1991;503-514.
54. Brady A.J.B., Warren J.B., Poole-Wilson P.A., Williams T.J., Harding S.E. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 265:1993;H176-H182.
55. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL. Effect of exogenous and endogenous nitricoxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991;260:C910-6.
56. Pisarenko O.I., Solomatina E.S., Studneva M., Ivanov V.E., Kapelko V.I., Smirnov V.N. Effect of glutamic and aspartic acids on adenine nucleotides, nitrogenous compounds and contractile function during underperfusion of isolated rat heart. J Mol Cell Cardiol. 15:1983;53-60.
57. Pisarenko O.I., Oleynikov O.D., Shulzhenko V.S., Studneva I.M., Ryff I.M., Kapelko V.I. Association of myocardial glutamate and aspartate pool and functional recovery of postichemic heart. Biochem Med Metab Biol. 42:1989;105-117.
58. Bernard M., Menasche P., Canioni P., et al. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates. J Thorac Cardiovasc Surg. 90:1985;235-242.